Level C· Early human research exploring benefitsCase Report / SeriesEurope PMCOpen access

Treatment of Recurrent Aneurysmal Bone Cyst in a Dog Using Bone Morphogenetic Protein-2-loaded Alginate Microbeads

Lee C., Kang KW., Kang BJ.

Case Report / Series on Hip, published in In Vivo (2025) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Case Report / Series
Journal
In Vivo (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40579036
PMCID
PMC12223652
DOI
10.21873/invivo.13997

Abstract (original English)

Background/aim Aneurysmal bone cysts (ABCs) are benign osteolytic lesions associated with lameness and present therapeutic challenges due to their frequent recurrence following surgery. This case report describes the surgical management and long-term outcomes of recurrent femoral ABC in a dog treated with multiple adjuvant therapies, including bone morphogenetic protein-2 (BMP-2)-loaded alginate microbeads. Case report A 2-year-old neutered male Golden Retriever presented with right hindlimb lameness. Three months before, the dog underwent initial surgical curettage and bone grafting of a femoral lesion, confirmed as ABC by histopathology. Radiographs revealed an osteolytic lesion in the right distal femur with resorption of previously applied bone grafts. Revision surgery involved curettage and a high-speed burring, followed by filling the defect with cancellous bone autografts, bone marrow, BMP-2-loaded alginate microbeads, and BMP-2-soaked cancellous bone allograft chips. The dog restored normal gait within two months postoperatively. Follow-up radiographs indicated progressive bone formation without recurrence. The dog remained asymptomatic 29 months after the revision surgery. Conclusion The combined use of a high-speed burr, BMP-2-loaded alginate microbeads, and bone graft materials resulted in favorable clinical outcomes in recurrent ABC, without recurrence up to 29 mont

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • Without an adequate control group, treatment effects cannot be separated from other factors.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
FemurAnimalsDogsBone Cysts, AneurysmalDog DiseasesRecurrenceAlginatesTreatment OutcomeBone TransplantationMicrospheres

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research